lenalidomide,carfilzomib
amgen
['mmsm', 'gem-cesar']
a third of patients in the gem-cesar trial of smoldering myeloma would have myeloma today based on slim criteria, limiting applicability of results to todays landscape.
#mmsm #ash22 
Cancer doctor at @huntsmancancer with interest in myeloma, supportive care, end of life, cost-effective/evidence-based care and med-ed. No COI. Views own.